Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Scientists at Weill Cornell Medicine have cracked the code on how a molecule called PIP2 fine-tunes light sensitivity in the eye's rod cells. By pinpointing exactly where PIP2 binds to a key ion channel (CNG), researchers have opened the door to targeted drug development for retinal diseases. The findings were published in Nature Communications.
Researchers at Weill Cornell Medicine have uncovered how a molecule called PIP2 — a phospholipid found in most human cell membranes — helps regulate how sensitive the eye's rod cells are to light. The study, published in Nature Communications, identified the precise binding site where PIP2 latches onto CNG ion channels in rod cells, effectively keeping them "closed" and modulating light sensitivity. This mechanism is especially relevant in low-light conditions and peripheral vision, where rod cells do the heavy lifting.
What makes the finding particularly exciting is that even at very low concentrations — which is typical in rod cells — PIP2 is potent enough to inhibit CNG channel activity. The team used model membranes with controlled PIP2 levels and cryogenic electron microscopy to map out the structural details of this interaction with unprecedented clarity.
Key Takeaways:
Why it matters: This is the first clear mechanistic picture of how PIP2 regulates rod-cell CNG channels, laying the groundwork for therapies targeting retinal degeneration and vision loss — conditions that currently have very limited treatment options.
